Baseline patient characteristics and GLP-1 plasma measurements of the ICU cohort
| Parameter . | All Patients . | Nonsepsis . | Sepsis . |
|---|---|---|---|
| N | 155 | 43 | 112 |
| Sex, male/female | 92/63 | 25/18 | 67/45 |
| Age, years | 64 (18–90) | 62 (18–85) | 66 (20–90) |
| APACHE II score | 17 (3–40) | 14.5 (3–28) | 18 (3–40) |
| Preexisting diabetes, n (%) | 50 (32.3%) | 15 (34.9%) | 35 (31.3%) |
| BMI, kg/m2 | 25.0 (15.3–61.0) | 26.5 (15.9–40.5) | 24.9 (15.3–61.0) |
| IL-6, pg/mL | 141.0 (47.0–518.0) | 159.0 (69.7–417.0) | 135.0 (47.0–518.0) |
| CRP, mg/dL | 116.5 (5–230) | 13 (5–230) | 165 (5–230) |
| Glucose, mg/dL | 141.0 (47.0–518.0) | 159.0 (69.7–417.0) | 135.0 (47.0–518.0) |
| Insulin, mU/L | 8.1 (0.2–1,000) | 32.0 (1.0–1,000) | 5.2 (0.2–438) |
| GLP-1, pmol/L | 97 (14.4–303.5) | 67.5 (17.2–303.5) | 101.1 (14.4–286.5) |
| Parameter . | All Patients . | Nonsepsis . | Sepsis . |
|---|---|---|---|
| N | 155 | 43 | 112 |
| Sex, male/female | 92/63 | 25/18 | 67/45 |
| Age, years | 64 (18–90) | 62 (18–85) | 66 (20–90) |
| APACHE II score | 17 (3–40) | 14.5 (3–28) | 18 (3–40) |
| Preexisting diabetes, n (%) | 50 (32.3%) | 15 (34.9%) | 35 (31.3%) |
| BMI, kg/m2 | 25.0 (15.3–61.0) | 26.5 (15.9–40.5) | 24.9 (15.3–61.0) |
| IL-6, pg/mL | 141.0 (47.0–518.0) | 159.0 (69.7–417.0) | 135.0 (47.0–518.0) |
| CRP, mg/dL | 116.5 (5–230) | 13 (5–230) | 165 (5–230) |
| Glucose, mg/dL | 141.0 (47.0–518.0) | 159.0 (69.7–417.0) | 135.0 (47.0–518.0) |
| Insulin, mU/L | 8.1 (0.2–1,000) | 32.0 (1.0–1,000) | 5.2 (0.2–438) |
| GLP-1, pmol/L | 97 (14.4–303.5) | 67.5 (17.2–303.5) | 101.1 (14.4–286.5) |
For quantitative variables, median (range) are given.